RNU6-70P

Across TCGA pan-cancer cohorts, RNU6-70P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-70P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU6-70P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-70P expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

READ, LIHC, and KICH are the cancer types where RNU6-70P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	All	0.555	0.917	<.001	126	view →
LIHC	OS	Tertile	III,IV	0.093	0.649	<.001	36	view →
KICH	DFS	Tertile	All	0.121	0.867	.023	15	view →
ESCA	DFS	Tertile	II,III,IV	0.273	0.512	.019	9	view →
SARC	OS	Tertile	All	0.248	0.771	<.001	9	view →
LUSC	DFS	Tertile	II,III,IV	0.819	0.697	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-70P–READ (OS)

Open the READ breakdown →